Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Patients undergoing lung resection due to pulmonary cancer can be compromised in their
postoperative period due to atrial fibrillation.
A retrospective analysis performed at our institution indicates that 30 % of the population
develope atrial fibrillation in the postoperative period.
Amiodarone is known to diminish the occurence of postoperative atrial fibrillation after
heart surgery, why this drug is chosen as a prophylactic agent for the mentioned population.
Amiodarone is administrated twice a day for 5 days at a dose of 600 mg oral treatment after
an initial loading bolus og 300 mg intravenously.